Investigation reveals cytotoxic effects and antioxidant capacity of ZnO nanoparticles from Canavalia rosea, suggesting potential therapeutic use.
The investigation confirms the biosynthesis of zinc oxide nanoparticles and their antiproliferative capacity; this is the preeminent study to utilise Canavalia rosea leaf and stem extracts. Characterization techniques including Energy-dispersive X-ray spectroscopy, X-ray Diffraction, Fourier-transform Infrared Spectroscopy, UV-Vis Spectroscopy, Field-Emission Scanning Electron Microscopy, and Photoluminescence reveal the structural properties. By employing the DPPH assay, the antioxidant capacity of Le-ZnONPs and Se-ZnONPs at various concentrations (μg ml-1), including 31.25, 62.5, 125, and 250, was assessed. According to FESEM analysis, the agglomerates of irregular-shaped zinc nanoparticles have a size range of 50 to 100 nm. In the DPPH assay, the antioxidant activity of both ZnONPs presented a more favourable response, with inhibition ranging from 80 to 90 percent. The cytotoxic effect of ZnONPs on MCF-7 cells was assessed by determining the IC50 values for Le-ZnONPs (52.08 μg ml-1) and Se-ZnONPs (636.3 μg ml-1). The substantial outcomes associated with the cytotoxic and antioxidant capacities of ZnONPs indicate that they may possess antiproliferative properties.
No takes yet. Share an insight, caveat, or question.
Vadive et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: